Skip to main content
RSA Conference 2024
Times are shown in your local time zone GMT

Hemodialysis for Pacific People; The National Kidney Foundation of Samoa Journey

Concurrent

Concurrent

10:00 am

14 June 2024

P10

Session 5b: Concurrent 2.1

Talk Description

449Q - Research Paper

Abstract
Aim:
Presentation will highlight the establishment of NKFSamoa, its essential services and identifying challenges and innovations experienced by the NKFSamoa in a resource constraint environment while ensuring these essential services are sustained for the people of Samoa. 

Method:
NKFS recent evaluation of statistics gathered from its medical screenings and outreach programs, suggests a prevalence of CKD in Samoa of 34.6%. This estimate suggests that given a population of about 200,000, there would be 42,212 people living with CKD in Samoa. This is a very high number compared to global rates 

Results:
Currently the number of patients requiring dialysis increased dramatically and the conditions these patients presented with were well advanced in kidney failure that there was no other intervention needed except initiating dialysis. From NKFS data for the 443 people that were on dialysis during the 10 years, 2012 – 2022, over 80% of them had End Stage Renal Failure due to unmanaged or poorly managed diabetes and/or hypertension.  Haemodialysis patients increased by 200%, more than 80% of patients in the pre-dialysis clinic were lost to follow up and our screening program was effective in detecting however lacking in management of people identified with CKD. 

Conclusion:
These numbers would suggest that Samoa will continue to experience a constant increase in people needing renal replacement therapy. This assumption is held true by having a new high of 66 new dialysis patients for the Financial Year ending 30 June 2023.

Presenters